Skip to content

Virechana karma in derranged lipid range

Clinical study to evaluate the effect of virechana karma in Dyslipidemia - nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/073876
Enrollment
40
Registered
2024-09-13
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E789- Disorder of lipoprotein metabolism, unspecified

Interventions

None listed

Sponsors

priya meena
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients fit for Virechana Karma S.cholesterol -more than 180mg/dl S. triglyceride - more than 150mg/dl S.LDL - more than 110mg/dl S.VLDL - more than 41mg/dl S.HDL - less than 40mg/d

Exclusion criteria

Exclusion criteria: Age less than 20 years or more than 60 years. Patients having serious cardiac problems such as myocardial infarction, cardiac failure,etc. Patients having serious renal disease. Drug-induced hyperlipidemia e.g. glucocorticoid-induced. Patients having a major illness like uncontrolled DM. Pregnant and lactating females

Design outcomes

Primary

MeasureTime frame
relief in following objective parameters Serum cholesterol more than 180mg/dl Serum triglyceride more than 150mg/dl Serum LDL more than 110mg/dl Serum VLDL more than 41mg/dl Serum HDL less than 40mg/dl Timepoint: 8 weeks

Secondary

MeasureTime frame
To improve quality of lifeTimepoint: 2 months

Countries

India

Contacts

Public ContactPriya meena

UAU, Gurukul campus

druksm27@gmail.com9411149479

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026